Navigation Links
Oncology is the Most Active Therapeutic Area for Phase II/III R&D
Date:11/21/2013

BURLINGTON, Mass., Nov. 21, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that while metabolic drugs account for one-quarter of drugs recently filed for approval or approved, oncology continues to be the most active therapeutic area for Phase II and III research and development (R&D). Among the top 25 biopharmaceutical companies, oncology is the focus for 30 percent of Phase II drugs and 22 percent of Phase III drugs. According to Decision Resources' Strategic Insights report entitled R&D Trends: Will Pharma's Investment Deliver?, other active therapeutic areas of R&D include obesity drugs, anti-diabetics, anti-infectives, central nervous system drugs, musculoskeletal/pain drugs and respiratory drugs.

The analysis also reveals that despite enduring multiple failures in 2011 and 2012 with drugs in Phase III development, Novartis is poised to benefit from a rich Phase III pipeline. Decision Resources expects Novartis will replace Pfizer as the top global biopharmaceutical company in 2015.

"To maximize R&D investments, biopharmaceutical companies must continue to address Phase II and III attrition and identify better prospects early on," said Decision Resources Group Senior Vice President Kate Hohenberg. "As more than half of the costs associated with new drugs are accrued from Phase II on, this could lead to significant cost savings."

About Decision Resources
Decision Resources (www.decisionresources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources Group company. <
'/>"/>

SOURCE Decision Resources
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Genelux, a Leader in the Emerging Oncolytic Virotherapy Field, Receives Significant Industry Honor from Elsevier Business Intelligence, Identifying GL-ONC1 as One of 2013s Top Oncology Projects to Watch
2. QIAGEN Announces Partnership With Clovis Oncology to Co-develop Companion Diagnostic Targeting Drug-Resistant EGFR Mutations
3. In The Face Of Increasing Healthcare Spend And High-Cost Targeted Treatment, Market Access Barriers Continue To Rise For Targeted Oncology Drugs
4. Elekta Opens Global Education Center for Oncology and Neuroscience Professionals
5. Enhanced Strategies for Design and Execution of Biomarker-driven Oncology Trials, new life science webinar hosted by Xtalks
6. Cancer Patients to See More Precise Oncology Treatment via Innovative Life Sciences Coalition
7. Oncology Therapeutics Market in India to 2018 Report
8. Vermillions OVA1 Receives New Statement by Society of Gynecologic Oncology
9. Closed Drug Transfer Systems: Oncology Therapeutics Market Dynamics and Closed Drug Transfer Design Factors - Market Forecasts to 2017
10. Ambit Announces Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the Annual Meeting of the American Society of Clinical Oncology
11. AbbVie Presents Results from Phase I Study of Investigational Oncology Compound ABT-199 at American Society of Clinical Oncology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Niagara Thermal Products is proud to announce that ... ("B3") as the critical thermal component supplier in support ... Corps of Engineers.  B3 has developed the only comprehensive ... destroys VOCs and other chemical pollutants, allergens and organic ...
(Date:1/15/2014)... and SAN JOSE, California , ... biotechnology company developing antibody-drug conjugates for cancer, today announced the ... of Directors. Dr Reynolds has over 20 years, development experience ... Officer at Seattle Genetics. "I am delighted to ...
(Date:1/15/2014)... A study has been launched to test ... track could help to tackle the problem of obesity.  This ... GP surgery based in Stowmarket) and academics at University Campus ... Telemetry technology, which is inspired by equipment used to collect ...
(Date:1/15/2014)... The Microcompetition with Foreign DNA theory explains ... these latent viruses is the Epstein Barr Virus (EBV), and ... (RA) is a chronic inflammatory disease that destroys the body’s ... RA patients have high concentrations of EBV DNA in their ...
Breaking Biology Technology:Niagara Thermal Products LLC Selected as Critical Supplier for Buffalo BioBlower Air Purification Systems 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3
... SAN DIEGO, Sept. 4 ADVENTRX Pharmaceuticals,Inc. (Amex: ... company,focused on commercializing proprietary product candidates for the ... Evan M. Levine,ADVENTRX,s chief executive officer is scheduled ... Conference on Monday, September 10th, 2007,at 8:30 a.m. ...
... Sept. 4 Six hospitals in,the north of ... VAR ),software system that enables them to ... for Medical Oncology at hospitals in Lancashire and,Cumbria ... efficiency by,fully integrating the prescribing, preparation, dispensing and,administration ...
... at Event in ... Hong Kong, China, ... that the leading China biometrics company Miaxis,Biometrics Co., Ltd has been ... 2007 awards. The news has been,announced at a gala dinner during ...
Cached Biology Technology:ADVENTRX Pharmaceuticals to Present at the 20th Annual Bear Stearns Healthcare Conference 2Six UK Hospitals Join Together in Using Varian Medical Oncology Information Network 2Six UK Hospitals Join Together in Using Varian Medical Oncology Information Network 3Miaxis Biometrics Named as 'Red Herring 100 Asia' Award Winner for 2007 2Miaxis Biometrics Named as 'Red Herring 100 Asia' Award Winner for 2007 3
(Date:4/21/2014)... 21, 2014 Performing brain research that can one ... of Houston (UH) junior Khanh (Kate) Nguyen has been ... A double major in mathematics and physics, Nguyen is ... Scholarship. , One of the most prestigious awards ... to sophomore and junior students majoring in mathematics, the ...
(Date:4/21/2014)... Earth Week--and in fact, every week now--trees in mountains across ... of bark beetles that reproduce in the trees, inner bark. ... mountain pine beetle, attack and kill live trees. Others live ... the mountain pine beetle has caused the deaths of more ... do all these dead trees have on stream flow and ...
(Date:4/21/2014)... Boobies are on the decline in the Galpagos. , A ... Ecology indicates numbers of the iconic birds, known for ... to attract mates, have fallen more than 50 percent in ... population is probably due to an unexplained disappearance of sardines ... biology at Wake Forest University and the study,s principal investigator. ...
Breaking Biology News(10 mins):UH student named Goldwater Scholar, 2 more receive honorable mention 2UH student named Goldwater Scholar, 2 more receive honorable mention 3UH student named Goldwater Scholar, 2 more receive honorable mention 4Earth Week: Bark beetles change Rocky Mountain stream flows, affect water quality 2Earth Week: Bark beetles change Rocky Mountain stream flows, affect water quality 3Lack of breeding threatens blue-footed boobies' survival 2Lack of breeding threatens blue-footed boobies' survival 3
... Hebrew University of,Jerusalem have succeeded in discovering and ... special structural and qualitative,characteristics that could have consequences ... cancer cells.,In addition to being obtained from plant ... large quantities as a recombinant protein in,bacteria, making ...
... the Hebrew University of,Jerusalem have succeeded in discovering ... with special structural and qualitative,characteristics that could have ... to cancer cells.,In addition to being obtained from ... in large quantities as a recombinant protein in,bacteria, ...
... GTP, a related energy currency) and transform it into ... dynein, proteins that use ATP to ferry intracellular cargo ... ATP-dependent assembly of actin or tubulin fibers itself can ... white blood cells toward pathogens is powered by the ...
Cached Biology News:The death of a very special chimpanzee 2New protein discovered by Hebrew University researchers 2DNA Recombination and Repair—A New Twist to RecA Function 2
... Hybri-slips are hydrophobic cover slips for ... to genomic arrays on glass slides., ... slips, Hybri-slips do not adsorb probes. ... prior to use. , Avoid RNA ...
These 22x40mm rectangular No.1 Corning cover glasses are made from No. 0211 zinc titania glass and are 0.16 to 0.19mm thick. • Approx. Pcs Oz : 73...
... in the Microsart e.motion are sterile-sealed, without protective ... specially designed individual package on a band. ... membrane filter units ensures that they are perfectly ... band guarantees uniform dispensing of the individual membrane ...
...
Biology Products: